−15JPY
−1.31 BJPY
202.19 MJPY
64.14 M
About NANO MRNA CO LTD
Sector
CEO
Shiro Akinaga
Headquarters
Tokyo
Website
Employees (FY)
17
Founded
1996
ISIN
JP3651120002
FIGI
BBG000V9N9X4
NANO MRNA Co., Ltd. engages in the research, development, and production of pharmaceuticals using micellar nanoparticles technology. The company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It also engages in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Kashiwa, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4571 is 178.00 JPY — it has decreased by 3.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange NANO MRNA CO LTD stocks are traded under the ticker 4571.
NANO MRNA CO LTD is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track NANO MRNA CO LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, 4571 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANO MRNA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 17.00 employees. See our rating of the largest employees — is NANO MRNA CO LTD on this list?